Benzinga | Jul 30, 2021 09:10AM EDT

Credit Suisse Maintains Outperform on Edwards Lifesciences, Raises Price Target to $126

Credit Suisse analyst Matt Miksic maintains Edwards Lifesciences (NYSE:EW) with a Outperform and raises the price target from $112 to $126.